DiaMedica Therapeutics Inc. DMAC
Nov 11, 2026, 11:30 AM EST
- YTD
- +22.36%
- 1 year
- +52.43%
DMAC free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-29,102,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Missing observations.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -29,102,000 | -7,001,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -22,101,000 | -3,349,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -18,752,000 | -7,160,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -11,592,000 | 680,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -12,272,000 | -3,056,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -9,216,000 | Not available | Not available |
| FY 2019 | 2019-12-31 | Not available | Not available | Not available |
| FY 2018 | 2018-12-31 | -5,746,000 | -1,824,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -3,922,000 | -928,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -2,994,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-08T14:23:06.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.